A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The Trump administration directed federal health officials to pause external communications last week, which prompted the ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

HHS announced plans to reevaluate agency practices to ensure they meet requirements under the Hyde Amendment, which prohibits ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...